Huxley SANSA Home Sleep Apnea Test (1000-00) vs PMcardio

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Powerful Medical

AI Verdict

Huxley SANSA focuses on comprehensive home sleep apnea and cardiac arrhythmia diagnosis using a wearable patch and multi-day monitoring. PMcardio, on the other hand, is an AI platform for rapid, expert-level interpretation of ECGs to assess a wide range of cardiac conditions at the point of care. While both tools leverage AI in cardiology, Huxley SANSA is geared towards remote diagnostics for sleep and cardiac rhythm, whereas PMcardio is designed for immediate ECG interpretation in clinical settings.

Choose Huxley SANSA Home Sleep Apnea Test (1000-00) if…

Choose Huxley SANSA if you need a comprehensive, app-free home sleep apnea test that also provides diagnostic insight into cardiac arrhythmias from a single, comfortable chest patch. This tool is ideal for streamlining care at the intersection of cardiology and sleep medicine, allowing for multi-day monitoring and automatic cellular data upload.

View Huxley SANSA Home Sleep Apnea Test (1000-00) →

Choose PMcardio if…

Choose PMcardio if you require rapid, AI-powered interpretation of standard 12-lead ECGs for the assessment of over 50 cardiac conditions, including acute events like STEMI and OMI, at the point of care. This platform is well-suited for emergency medicine, cardiology, and internal medicine settings where quick, accurate ECG analysis and clinical decision support are critical.

View PMcardio →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Huxley SANSA Home Sleep Apnea Test (1000-00) PMcardio
Pricing Contact for pricing Freemium
Deployment Cloud-based algorithm with cellular data upload from device Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems
BAA Available Yes AI-estimated Unknown
FDA Status Yes AI-estimated Pending AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Huxley SANSA Home Sleep Apnea Test (1000-00)

Huxley SANSA offers an app-free, cellular-enabled wearable patch, simplifying the patient experience by eliminating the need for smartphones, Bluetooth pairing, or manual data uploads. PMcardio, while offering mobile and web platforms, requires active engagement with an app for ECG analysis and report viewing, which can be a barrier for some users.

Clinical Value

PMcardio

PMcardio demonstrates broader clinical utility by interpreting over 50 cardiac conditions from ECGs, including advanced detection of STEMI/OMI and reduced LVEF, validated in over 25 studies. Huxley SANSA focuses on home sleep apnea and cardiac arrhythmia diagnosis, with strong validation against polysomnography for sleep apnea, but its cardiac diagnostic scope appears more limited to arrhythmias.

Pricing & Value

PMcardio

PMcardio offers a transparent freemium model with a free plan for 5 ECG analyses per month and clearly stated pricing for individual and team subscriptions. Huxley SANSA's pricing is 'contact for pricing,' which lacks transparency and may be a barrier for initial evaluation or smaller practices.

Enterprise Readiness

PMcardio

PMcardio offers enterprise integrations with EHR/CVIS and EMS systems, indicating a strong focus on large-scale deployment and workflow integration within healthcare organizations. Huxley SANSA, while offering different service models for providers (SANSA Go, SANSA Express, SANSA 360), does not explicitly detail EHR integration capabilities in the provided information.

Innovation

Tie

Both tools demonstrate significant innovation in their respective domains. Huxley SANSA's app-free, cellular-enabled wearable patch for multi-day home sleep apnea and cardiac arrhythmia diagnosis is a novel approach to remote monitoring. PMcardio's AI explainability features with heatmaps (ECGxplainu2122) and its ability to detect subtle occlusion MI patterns and reduced LVEF from standard ECGs showcase advanced AI application in cardiology.

Support & Docs

PMcardio

PMcardio provides a dedicated 'Trust Center' for compliance and security, a 'Help Center' with tutorials and manuals, and an FAQ section, indicating comprehensive documentation and support resources. Huxley SANSA mentions 24/7/365 patient support for its SANSA Express service model, but a broader range of publicly available documentation for healthcare providers is not explicitly detailed.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Huxley SANSA Home Sleep Apnea Test (1000-00) PMcardio
Tool Name Huxley SANSA Home Sleep Apnea Test (1000-00) PMcardio
Company Huxley Medical Powerful Medical
Description FDA-cleared, AI-powered wearable patch for home sleep apnea and cardiac arrhythmia diagnosis, offering an app-free, cellular-enabled solution for streamlined patient care. CE-certified AI platform that interprets ECGs to assess over 50 cardiac conditions rapidly and accurately.
Key Functionality Home sleep apnea and cardiac arrhythmia diagnosis (9 physiological data channels) ECG interpretations for 50+ cardiac conditions
Specialties Cardiology, Pulmonology, Sleep Medicine Cardiology, Emergency Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring Huxley SANSA Home Sleep Apnea Test (1000-00) and PMcardio.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Huxley SANSA offers an app-free, cellular-enabled solution for home sleep apnea and cardiac arrhythmia diagnosis, streamlining patient care with automatic data upload. PMcardio integrates with existing ECG systems, EHR/CVIS, and EMS systems, aiming to provide a unified cardiac AI platform for various care settings. PMcardio also offers professional ECG diagnostic reports that can be exported and integrated into patients' electronic health records.
Huxley SANSA demonstrated 88% sensitivity and 87% specificity for detecting moderate-to-severe Obstructive Sleep Apnea (OSA) when compared to polysomnography (PSG). It also showed 100% sensitivity and 99% specificity for Central Sleep Apnea (CSA) detection. PMcardio's AI ECG model achieved 86% sensitivity and 92% specificity for major ECG abnormalities, and 97% sensitivity and 99% specificity for atrial fibrillation in a primary care setting. For STEMI detection, PMcardio has shown 100% sensitivity in true positive STEMI patients and a 68% reduction in false positive STEMI alerts.
Huxley SANSA, with its ability to assess both sleep apnea and ECG, is positioned to benefit specialties beyond cardiology, pulmonology, and sleep medicine, such as electrophysiology, by identifying arrhythmias during sleep testing. PMcardio, while focused on cardiology, emergency medicine, and internal medicine, can also serve general practitioners by providing expert-level ECG interpretations and treatment recommendations based on the latest guidelines.
Huxley SANSA is designed for ease of use with a hands-free, app-free workflow, suggesting a minimal learning curve for patient setup and data collection. PMcardio aims to be an 'expertise extender' for physicians, providing rapid AI-powered interpretations that can help bridge skills gaps in ECG interpretation, particularly for less experienced staff.
PMcardio for Organizations includes features for audit trails and leadership reporting to track pathway performance across sites and teams, supporting QA and protocol optimization. It also offers detailed ECG report history for documentation and audits. Huxley SANSA's detailed physiological data channels and AI-powered auto-scoring would provide a robust data set for internal auditing of sleep apnea diagnoses.
Huxley SANSA offers different service models, including a direct-to-patient testing model where logistics are managed by Huxley, suggesting scalability for various practice sizes. PMcardio for Organizations is specifically designed for multi-site cardiac care delivery, offering one integration and one governance model that scales across campuses and care settings.

Backers

Who funded each tool's parent company.

PMcardio

AI Tool Finder
AI-powered search. Results may not be comprehensive.